Acadia Pharmaceuticals price target cut to $36 by RBC
RBC Capital cut its ACADIA Pharmaceuticals price target to $36.00 from $37.00 while maintaining an Outperform rating, per Benzinga via TradingView.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
RBC Capital cut its ACADIA Pharmaceuticals price target to $36.00 from $37.00 while maintaining an Outperform rating, per Benzinga via TradingView.